ZYGREL 75mg Price

Overview

Welcome to Dwaey, specifically on ZYGREL 75mg Tablets/Film-coated page.
This medicine contains an important and useful components, as it consists of Clopidogrel (as besylate).
ZYGREL 75mg is available in the market in concentration 75mg/Tablet and in the form of Tablets/Film-coated.

OMAN PHARMACEUTICAL PRODUCTS is the producer of ZYGREL 75mg and it is imported from OMAN, The most popular alternatives of ZYGREL 75mg are listed downward .

Mode Of Action

Clopidogrel inhibits adenosine diphosphate (ADP) from binding to its receptor sites on the platelets and subsequent activation of glycoprotein GP IIb/IIIa complex thus preventing fibrinogen binding, platelet adhesion and aggregation.

Indication

• Coronary Artery Disease
• Acute coronary syndrome
• Myocardial infarction
• Peripheral vascular disease
• Cerebrovascular disease
• Atherosclerosis
• Thromboembolic disorders
• Unstable angina
• Stroke

Precaution

Patients at risk of increased bleeding from trauma, surgery, or other pathological conditions; ulcer; renal and hepatic impairment; history of bleeding or haemostatic disorders. Pregnancy. Lactation: Not known whether drug is excreted in breast milk; not recommended

Side Effects

• 1-10% Upper respiratory tract infection (8.7%)
• Chest pain (8.3%)
• Headache (7.6%)
• Flulike syndrome (7.5%)
• Arthralgia (6%)
• Pain (6%)
• Dizziness (6%)
• Diarrhea (4.5%)
• Rash (4.2%)
• Rhinitis (4.2%)
• Depression (3.6%)
• Urinary tract infection (3.1%) <1% Severe neutropenia
• Thrombotic thrombocytopenic purpura
• Acute liver failure
• Aplastic anemia
• Hypotension
• Hepatitis
• Myalgia
• Eczema
• Erythema
• Agranulocytosis Potentially Fatal: Bleeding disorders including GI and intracranial haemorrhage. Blood dyscrasias.

Contra indication

Hypersensitivity. Active pathological bleeding. admin within 7 days after MI and ischaemic stroke, coagulation disorders. Lactation.

Pregnancy and lactation

Pregnancy category: B

Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.